ILIAS NIGAMATOV: Open Payments
NPI 1497831820 · ST. THOMAS, VI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 7 payments from 5 companies in 2025. Trend: 2023 $867 · 2024 $698 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: INGREZZA, CAPLYTA, REXULTI, HETLIOZ.
Industry payments across VI — which companies pay providers there.
